- Slice of Agriculture
- Posts
- SOLASTA Bio Secures $14M Series A to Develop Sustainable Bioinsecticides
SOLASTA Bio Secures $14M Series A to Develop Sustainable Bioinsecticides
Slice of Agriculture Team
September 13, 2024
Key Highlights:
$14M Series A funding led by Forbion, FMC Ventures, and Corteva Catalyst.
Unique peptide-based bioinsecticides for eco-friendly crop protection.
Successful 2023 trials showed efficacy on par with current insecticides.
SOLASTA Bio is targeting a $27B market with market entry planned for 2027.
Focus on pollinator protection and tackling insect resistance.
Source (Globe Newswire)
Notable Quotes:
"With Series A now secured, it’s time for SOLASTA Bio to kick on to the next level and successfully hit our targets for commercialisation.”
“SOLASTA is poised to revolutionise the crop protection market at a critical time, with a sustainable and high-efficacy alternative.”
“SOLASTA’s nature-inspired approach to insect control is a game changer in crop protection.”
Our Take:
SOLASTA Bio's $14M Series A funding marks a pivotal moment for the agri-biotech industry. By focusing on nature-inspired, peptide-based insecticides, SOLASTA addresses two key global concerns: the rising issue of insect resistance and the urgent need to protect beneficial pollinators. Their innovative approach, which demonstrated promising results in 2023 trials, positions them as a frontrunner in the bioinsecticide market. With strategic backing from major agricultural players like FMC Ventures and Corteva Catalyst, SOLASTA Bio is well-positioned to commercialize their eco-friendly solutions, with potential market entry as early as 2027—a significant leap forward for sustainable agriculture.